The globalclinical trial supplies marketsize was estimated at USD 5.7 billion in 2025 and is projected to reach USD 10.7 billion by 2033, growing at a CAGR of 8.4% from 2026 to 2033. The market growth is driven by increasing RD investments, the rising prevalence of chronic diseases, and the globalization of clinical trials. Growing demand for efficient clinical trial operations and increasing focus on the development of innovative therapies are also contributing significantly to market expansion worldwide.
Clinical trial supplies include products and services required for conducting clinical studies, such as investigational drugs, packaging, labeling, storage, distribution, and supply chain management solutions. These supplies play a critical role in ensuring smooth clinical trial operations, maintaining product quality, and meeting regulatory compliance standards. Increasing pharmaceutical and biotechnology research activities and the growing number of clinical studies across multiple therapeutic areas are supporting the growth of the clinical trial supplies market.
Key Market Trends Insights
- North America clinical trial supplies market held the largest share of 43.8% of the global market in 2025. The regions dominance is supported by the strong presence of pharmaceutical and biotechnology companies, advanced healthcare infrastructure, and high investment in research and development activities. Increasing clinical trial activity and rising demand for advanced supply chain management services are contributing to market growth across North America. In addition, supportive regulatory frameworks and growing adoption of innovative drug development technologies are strengthening the regional market.
- The clinical trial supplies market in the U.S. is expected to grow significantly over the forecast period. The country continues to witness increasing pharmaceutical research activities, rising investments in drug development, and growing demand for advanced clinical trial management solutions. The presence of major clinical research organizations and pharmaceutical manufacturers is supporting market expansion in the U.S. Furthermore, increasing focus on personalized medicine and advanced therapeutic development is contributing to higher demand for clinical trial supplies and related services.
- Based on the phase, the phase III segment led the market with the largest revenue share of 53.1% in 2025. Phase III clinical trials involve large patient populations and extensive testing procedures to evaluate the safety and effectiveness of investigational therapies before regulatory approval. These trials require substantial quantities of clinical supplies, logistics support, packaging, and distribution services, which is contributing to the dominance of the segment. Increasing development of new drugs and biologics is further supporting the growth of phase III clinical trial activities globally.
- Based on service, the supply chain management segment accounted for the largest market revenue share in 2025. Supply chain management services are essential for ensuring the timely storage, transportation, tracking, and distribution of clinical trial materials across multiple research sites and countries. Growing complexity of global clinical trials and increasing regulatory requirements are driving demand for efficient supply chain management solutions. Pharmaceutical companies are increasingly focusing on improving inventory management and maintaining product integrity throughout the clinical trial process.
- Based on therapeutic use, the oncology segment accounted for the largest market revenue share in 2025. The high prevalence of cancer worldwide and increasing investment in oncology drug development are major factors supporting segment growth. Pharmaceutical and biotechnology companies are conducting a large number of oncology clinical trials focused on targeted therapies, immunotherapies, and personalized treatment solutions. Rising demand for advanced cancer treatment options and increasing research activities in oncology are contributing significantly to the expansion of this segment within the clinical trial supplies market.
Looking for more specific insights? Customize this report to suite your business needs
Key Companies Market Share Insights
The key players operating across the market are adopting strategic initiatives such as service and product launches, mergers acquisitions, partnerships agreements, and expansions to gain a competitive edge in the market. For instance, in January 2023, Catalent launched a supply case management service for cell and gene therapy supply chains, providing end-to-end coordination, traceability, and logistics oversight. The initiative improves delivery reliability, reduces disruption risks, and enhances operational control for advanced therapy clinical trial distribution globally.
Key Clinical Trial Supplies Companies:
- Almac Group
- Biocair
- Catalent Inc.
- KLIFO
- Movianto
- PCI Pharma Services
- Sharp Services, LLC
- Thermo Fischer Scientific Inc.
- United Parcel Service of America, Inc (UPS Healthcare)
- Parexel International Corporation
Grand View Research offers
- Focused market intelligence reports on specific geographies or high-growth segments.
- Extended forecast timelines for long-term planning.
- Competitor Benchmarking and Supply Chain Analysis
- Inclusion of regulatory and policy assessments.
- Inclusion of custom data models, KPIs, or applications unique to your business
- Specific high-impact Data Decks and Tables to support effective decision making
- And much more
Looking for a report customized to your requirements?Explore our Custom Research Offering
